Clinical Trial Update: A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer [Phase 2, Phase 3]

View source ↗

Summary

The document provides an update on a Phase 2/Phase 3 trial evaluating abiraterone acetate plus prednisone with or without abemaciclib (LY2835219) in prostate ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)
• Abiraterone acetate (Abiraterone acetate)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Prostate Cancer | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-03-06